A 17-year-old female patient with hypertrophic cardiomyopathy and pre-excitation in ECG (after two-fold RF ablation—radiofrequency catheter ablation), treated with Sotalol, in whom genetic testing revealed heterozygous deletion in the LAMP2 region typical for Danon disease. Here, LAMP2 is linked to hypertrophic cardiomyopathy.